Quest PharmaTech Inc.
QPT.V
TSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -3.58% | -21.73% | -21.60% | -33.98% | -42.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.83% | -14.04% | -3.63% | -35.91% | -39.65% |
| Operating Income | 12.83% | 14.04% | 3.63% | 35.91% | 39.65% |
| Income Before Tax | 385.68% | 96.51% | 62.25% | 94.54% | 42.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 385.68% | 96.51% | 62.25% | 94.54% | 42.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 385.68% | 96.51% | 62.25% | 94.54% | 42.87% |
| EBIT | 12.83% | 14.04% | 3.63% | 35.91% | 39.65% |
| EBITDA | -- | 70.31% | 36.83% | 44.90% | 39.74% |
| EPS Basic | 386.67% | 96.74% | 62.99% | 95.18% | 43.61% |
| Normalized Basic EPS | 269.44% | 121.05% | 46.15% | 78.79% | 23.40% |
| EPS Diluted | 386.67% | 96.74% | 62.99% | 95.18% | 43.61% |
| Normalized Diluted EPS | 269.44% | 121.05% | 46.15% | 78.79% | 23.40% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |